Spotlight on Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Author： Cvetković Risto S.   Perry Caroline M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.4, 2006-01, pp. : 253-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Rituximab in Chronic Lymphocytic Leukemia, Low-Grade or Follicular Lymphoma, and Diffuse Large B-Cell Lymphoma†

By Keating Gillian M.  

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 55-61

Adis International

Access to resources Recommend Favorite

Radioimmunotherapy: Potential as a Therapeutic Strategy in Non-Hodgkin's Lymphoma

By Wun T.   Kwon D.S.   Tuscano J.M.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 151-162

Adis International

Access to resources Recommend Favorite

Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma: Targeting the Idiotypic Immunoglobulin

By Armstrong Anne C.   Cheadle Eleanor J.   Hawkins Robert E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma

By Cheson Bruce D.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 309-322

Adis International

Access to resources Recommend Favorite

Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia

By Robak Tadeusz  

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 9-22

Adis International

Access to resources Recommend Favorite